TERRI POLLACK: Open Payments
NPI 1104112150 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,643 in 33 payments from 9 companies in 2025. Trend: 2023 $11,161 · 2024 $8,237 · 2025 $10,643
Speaker / faculty: $5,655Travel & lodging: $2,571Honoraria: $1,450Food & beverage: $929Consulting: $39
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 15 | $7,634 |
| Exelixis Inc. | 9 | $2,711 |
| Astellas Pharma US Inc | 1 | $78 |
| Ipsen Biopharmaceuticals, Inc | 1 | $76 |
| Caris MPI, Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ECS OPCO 1 LLC | 1 | $14 |
Products named: Pemazyre, CABOMETYX, Vyloy, Onivyde, MI CANCER SEEK, PLUVICTO, XTANDI, Nubeqa.
Industry payments across FL — which companies pay providers there.
